Filter
1334
Filtered Results: 1334
Text search:
charge
du
patient
Featured
Recommendations
142
New Publications
248
Language
Document type
No document type
601
Guidelines
267
Studies & Reports
218
Manuals
89
Strategic & Response Plan
57
Training Material
40
Fact sheets
34
Situation Updates
10
Brochures
9
Infographics
7
Dashboards/Maps
1
Resource Platforms
1
Countries / Regions
South Africa
154
Congo, Democratic Republic of
103
Senegal
74
Burkina Faso
60
Guinea
41
Global
39
Benin
32
Rwanda
29
Africa
29
Mali
28
South–East Asia Region
27
Cameroon
26
West and Central Africa
26
Haiti
22
Côte d’Ivoire / Ivory Coast
22
Western and Central Europe
21
Liberia
19
Sierra Leone
16
Nigeria
16
East and Southern Africa
14
Uganda
14
Central African Republic
14
India
14
Kenya
13
Middle East and North Africa
12
Madagascar
12
Niger
11
Germany
11
Western Pacific Region
10
Chad
9
Togo
8
Latin America and the Carribbean
8
France
8
Syria
7
Malawi
7
Mozambique
7
South Sudan
7
Ghana
6
Tanzania
6
North America
6
Russia
6
Myanmar / Burma
6
Zimbabwe
5
Cambodia
5
North Macedonia
4
Nepal
4
Ukraine
4
Morocco
4
Philippines
4
Eastern Europe and Central Asia
4
Vietnam
4
Namibia
4
Tajikistan
3
Switzerland
3
Laos
3
Burundi
3
Eastern Europe
3
Brazil
3
Yemen
3
Botswana
3
Pakistan
3
Colombia
2
Mexico
2
Canada
2
Kyrgyzstan
2
Congo-Brazzaville
2
Afghanistan
2
Armenia
2
USA
2
Asia
2
Gabon
2
Portugal
2
Argentina
2
Bangladesh
2
Georgia
2
Ethiopia
2
Angola
2
Zambia
2
Indonesia
2
Iraq
2
Thailand
1
Serbia
1
Lesotho
1
Turkey
1
Kazakhstan
1
Chile
1
Uzbekistan
1
Austria
1
Qatar
1
Guinea-Bissau
1
Hungary
1
Luxembourg
1
Jamaica
1
Belgium
1
Mauritius
1
United Kingdom
1
Norway
1
Spain
1
Algeria
1
Lebanon
1
Sri Lanka
1
Djibouti
1
Greece
1
Palestine
1
Libya
1
Somalia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
493
Clinical Guidelines
153
Public Health
59
Women & Child Health
51
Key Resources
51
Capacity Building
27
Pharmacy & Technologies
22
Toolboxes
COVID-19
150
Ebola & Marburg
103
TB
94
Mental Health
90
HIV
70
Caregiver
64
AMR
53
NTDs
46
Rapid Response
43
Pharmacy
33
Malaria
30
Refugee
29
Disability
24
Planetary Health
19
NCDs
18
Cholera
14
Conflict
13
2.0 Rapid Response
11
Health Financing Toolbox
9
Specific Hazards
6
Social Ethics
6
Polio
6
Global Health Education
6
Zika
5
Natural Hazards
3
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE...
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of an inactivated severe acute respiratory syndrome c...
Driving progress towards rabies elimination: Results of Gavi’s Learning Agenda on rabies and new WHO position on rabies immunization
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I...
Infection preventions
Hygiene
Detailed adapted physical activities are provided with practical guides, group sport guides and assessment tools in order to promote a more inclusive society through sports
The German Institute for Human Rights annually submits a report on the development of the human rights situation in Germany to the German Federal Parliament (in accordance with sec. 2 para. 5 of the Act regarding the Legal Status and Mandate of the German Institute for Human Rights of 16 July 2015; ...
Framework for implementation.
The END TB Strategy.
Guidelines on Management of COVID-19 in Kenya
recommended
It has been over a year since Kenya identified the first case of COVID-19 in the country. The Government formed the National COVID-19 task force, which supported the country's response through multi-sectoral technical working groups on testing, case management, risk communication and community engag...
A Provisional Document. The purpose of this manual is to provide guidance to public health professionals tasked with managing a response to viral hepatitis. As every country’s needs are different with respect to its epidemiology and the current level of response, people would use this manual in di...
A handbook for leaders and managers
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been...
The chapter Fostering Health Systems’ Monitoring to Better Serve Older Populations is part of the publication series entitled Decade of Healthy Aging: Situation and Challenges. The publications are designed to favor the prioritization of effective actions at the local level as well as the monitori...
Bull World Health Organ 2020;98:773–780
Universal health coverage (UHC) depends on a strong primary health-care
system. To be successful, primary health care must be expanded at community and household levels as much of the world’s population still lacks access to health facilities for basic...
The WHO Cholera Rapid Diagnostic Test (RDT) Target Product Profile outlines the key requirements for developing improved cholera RDTs. It highlights the need for fast, accurate, and easy-to-use tests for early outbreak detection in resource-limited settings. The document sets desired and acceptable ...
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions speci...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
A compendium of TB REACH case studies, lessons learned and a monitoring and evaluation framework.
Accessed November 2017.
Promoting and protecting health is essential to human welfare and sustained economic and social development. This was recognized more than 30 years ago by the Alma-Ata Declaration signatories, who noted that Health for All would contribute
both to a better quality of life and also to global peace a...
